Comparative evaluation of the VITEK 2, disk diffusion, etest, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 10, 2007, Pages 3726-3730

  Lo Ten Foe, Jerome R ^a   De Smet, Anne Marie G A ^b   Diederen, Bram M W ^a,d   Kluytmans, Jan A J W ^a,c   Van Keulen, Peter H J ^a  

^a AMPHIA HOSPITAL   (Netherlands)

^b Utrecht Medical Center   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Laboratory of Public Health Haarlem   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; COLISTIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DIFFUSION; DRUG SENSITIVITY; ENTEROBACTER CLOACAE; INTENSIVE CARE UNIT; INTERMETHOD COMPARISON; MUTATION; NONHUMAN; PRIORITY JOURNAL; RELIABILITY;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; AGAR; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; COLISTIN; CROSS INFECTION; CULTURE MEDIA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; INTENSIVE CARE UNITS; MICROBIAL SENSITIVITY TESTS; POLYMYXIN B;

EID: 34948888732     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01406-06     Document Type: Article

References (22)

1. Andrews, J., R. Walker, and A. King. 2002. Evaluation of media available for testing the susceptibility of Pseudomonas aeruginosa by BSAC methodology. J. Antimicrob. Chemother. 50:479-486.
2. Andrews, J. M. 2001. The development of the BSAC standardized method of disc diffusion testing. J. Antimicrob. Chemother. 48(Suppl. 1):29-42.
3. Arroyo, L. A., A. Garcia-Curiel, M. E. Pachon-Ibanez, A. C. Llanos, M. Ruiz, J. Pachon, and J. Aznar. 2005. Reliability of the Etest method for detection of colistin resistance in clinical isolates of Acinetobacter baumannii. J. Clin. Microbiol. 43:903-905.
4. Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing. Fifteenth information supplement (M100-S15). Clinical and Laboratory Standards Institute, Wayne, PA.
5. Clinical and Laboratory Standards Institute. 2007. Performance standards for antimicrobial susceptibility testing. Seventeenth information supplement (M100-S17). Clinical and Laboratory Standards Institute, Wayne, PA.
6. Evans, M. E., D. J. Feola, and R. P. Rapp. 1999. Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria. Ann. Pharmacother. 33:960-967.
7. Falagas, M. E., and S. K. Kasiakou. 2005. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin. Infect. Dis. 40:333-341.
8. Gales, A. C., A. O. Reis, and R. N. Jones. 2001. Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines. J. Clin. Microbiol. 39:83-90.
9. Goldstein, F. W., A. Ly, and M. D. Kitzis. 2007. Comparison of Etest with agar dilution for testing the susceptibility of Pseudomonas aeruginosa and other multidrug-resistant bacteria to colistin. J. Antimicrob. Chemother. 59:1039-1040.
10. Jones, R. N., T. R. Anderegg, J. M. Swenson, and the Quality Control Working Group. 2005. Quality control guidelines for testing gram-negative control strains with polymyxin B and colistin (polymyxin E) by standardized methods. J. Clin. Microbiol. 43:925-927.
11. Landrygan, J., P. A. James, D. Brooks, and E. M. Kubiak. 2002. Reproducibility of control organism zone diameters for batches of IsoSensitest agar manufactured from 1996 to 2000 using the BSAC disc susceptibility test method. J. Antimicrob. Chemother. 49:391-394.
12. Li, J., C. R. Rayner, R. L. Nation, R. J. Owen, D. Spelman, K. E. Tan, and L. Liolios. 2006. Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 50:2946-2950.
13. Li, J., R. L. Nation, J. D. Turnidge, R. W. Milne, K. Coulthard, C. R. Rayner, and D. L. Paterson. 2006. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect. Dis. 6:589-601.
14. Li, J., R. L. Nation, R. W. Milne, J. D. Turnidge, and K. Coulthard. 2005. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria. Int. J. Antimicrob. Agents 25:11-25.
15. MacGowan, A. P., and R. Wise. 2001. Establishing MIC breakpoints and the interpretation of in vitro susceptibility tests. J. Antimicrob. Chemother. 48:(Suppl. 1):17-28.
16. Nicodemo, A. C., M. R. Araujo, A. S. Ruiz, and A. C. Gales. 2004. In vitro susceptibility of Stenotrophomonas maltophilia isolates: comparison of disc diffusion, Etest and agar dilution methods. J. Antimicrob. Chemother. 53:604-608.
17. Pollock, H. M., B. H. Minshew, M. A. Kenny, and F. D. Schoenknecht. 1978. Effect of different lots of Mueller-Hinton agar on the interpretation of the gentamicin susceptibility of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 14:360-367.
18. SFM Antibiogram Committee. 2003. Comite de l'Antibiogramme de la Société Française de Microbiologie report 2003. Int. J. Antimicrob Agents. 21:364-391.
19. Storm, D. R., K. S. Rosenthal, and P. E. Swanson. 1977. Polymyxin and related peptide antibiotics. Annu. Rev. Biochem. 46:723-763.
20. Tan, T. Y., and L. S. Ng. 2006. Comparison of three standardized disc susceptibility testing methods for colistin. J. Antimicrob. Chemother. 58:864-867.
21. Tan, T. Y., and S. Y. Ng. 2006. The in-vitro activity of colistin in gram-negative bacteria. Singapore Med. J. 47:621-624.
22. Tan, T. Y., and S. Y. Ng. 2007. Comparison of Etest, Vitek and agar dilution for susceptibility testing of colistin. Clin. Microbiol. Infect. 13:541-544.